Crossmark

Efficacy and safety of generic escitalopram (Lexacure) in patients with major depressive disorder: A 6-week, multi-center, randomized, rater-blinded, escitalopram-comparative, non-inferiority study

Crossref DOI link: https://doi.org/10.1016/j.eurpsy.2016.01.560

Published Online: 2020-03-23

Published Print: 2016-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jeong, J.H.

Bahk, W.M.

Woo, Y.S.

Lee, K.U.

Kim, M.D.

Kim, W.

Yang, J.C.

Lee, K.H.

Lee, S.Y.
License Information

License valid from 2020-03-23

Text and Data Mining valid from 2016-03-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of generic escitalopram (Lexacure) in patients with major depressive disorder: A 6-week, multi-center, randomized, rater-blinded, escitalopram-comparative, non-inferiority study

Journal Title: European Psychiatry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eurpsy.2016.01.560

Content Type: simple-article

Copyright: Copyright © 2016 Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below